$XPO stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $328,917,223 of trading volume.
It has been the 167th most-searched ticker on Quiver Quantitative over the last day, out of 10,089 total tickers searched.
Here is what we see in our data on $XPO (you can track the company live on Quiver's $XPO stock page):
$XPO Insider Trading Activity
$XPO insiders have traded $XPO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $XPO stock by insiders over the last 6 months:
- ALLISON LANDRY sold 3,250 shares for an estimated $438,869
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XPO Hedge Fund Activity
We have seen 247 institutional investors add shares of $XPO stock to their portfolio, and 283 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. added 1,036,434 shares (+19.8%) to their portfolio in Q3 2025, for an estimated $133,979,823
- DURABLE CAPITAL PARTNERS LP added 736,224 shares (+20.5%) to their portfolio in Q3 2025, for an estimated $95,171,676
- CAPITAL WORLD INVESTORS added 735,450 shares (+7.3%) to their portfolio in Q3 2025, for an estimated $95,071,621
- D1 CAPITAL PARTNERS L.P. removed 639,178 shares (-20.3%) from their portfolio in Q3 2025, for an estimated $82,626,540
- HOLOCENE ADVISORS, LP removed 495,836 shares (-57.8%) from their portfolio in Q3 2025, for an estimated $64,096,719
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 444,627 shares (+17.7%) to their portfolio in Q3 2025, for an estimated $57,476,932
- CANNELL & SPEARS LLC removed 394,503 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $49,821,783
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$XPO Congressional Stock Trading
Members of Congress have traded $XPO stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $XPO stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$XPO Analyst Ratings
Wall Street analysts have issued reports on $XPO in the last several months. We have seen 12 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/17/2025
- TD Cowen issued a "Buy" rating on 10/31/2025
- JP Morgan issued a "Overweight" rating on 10/31/2025
- Citigroup issued a "Buy" rating on 10/31/2025
- Stifel issued a "Buy" rating on 10/31/2025
- Raymond James issued a "Outperform" rating on 10/14/2025
- Benchmark issued a "Buy" rating on 10/01/2025
To track analyst ratings and price targets for $XPO, check out Quiver Quantitative's $XPO forecast page.
$XPO Price Targets
Multiple analysts have issued price targets for $XPO recently. We have seen 16 analysts offer price targets for $XPO in the last 6 months, with a median target of $150.0.
Here are some recent targets:
- Ken Hoexter from B of A Securities set a target price of $158.0 on 12/02/2025
- Brandon Oglenski from Barclays set a target price of $160.0 on 11/17/2025
- J. Bruce Chan from Stifel set a target price of $149.0 on 10/31/2025
- Christopher Kuhn from Benchmark set a target price of $150.0 on 10/31/2025
- Jason Seidl from TD Cowen set a target price of $141.0 on 10/31/2025
- Brian Ossenbeck from JP Morgan set a target price of $166.0 on 10/31/2025
- Ariel Rosa from Citigroup set a target price of $159.0 on 10/31/2025
You can track data on $XPO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
